Nuclear Medicine and Biology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.1 | Q2 | 68.2% | 0.748 | Q2 | 75.1% |
| 2024 | 3.0 | Q2 | 72.9% | 0.742 | Q2 | 75.5% |
| 2023 | 3.6 | Q1 | 82.5% | 0.658 | Q2 | 73.7% |
| 2022 | 3.1 | Q2 | 68.3% | 0.512 | Q2 | 67.0% |
| 2021 | 2.9 | Q3 | 61.1% | 0.458 | Q3 | 64.3% |
| 2020 | — | — | 0.554 | Q2 | 69.4% | |
| 2019 | — | — | 0.571 | Q2 | 71.2% | |
| 2018 | — | — | 0.674 | Q2 | 74.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1872-9614
ISSN
0969-8051
region
Northern America
coverage
1986-2026